Systematic reviewindependent cross-checkabstract checked I-CAN-126 standard review

Weight loss and survival in bowel and pancreatic cancer

The mortality burden of cachexia or weight loss in patients with colorectal or pancreatic cancer: A systematic literature review.

Overview

Dunne RF et al.. J Cachexia Sarcopenia Muscle 2024 · PMID 39095951 · DOI 10.1002/jcsm.13510

In about two-thirds of studies, cancer patients with wasting or weight loss lived shorter.

Does the study support the specific claim? Partly · Methodological quality: moderate

Study explained simply

What did the researchers want to find out?: Link cachexia and survival.
How was the study done?: Systematic review.
How many people, animals or samples were studied?: 26 studies.
What was actually found?: Wasting linked to shorter survival.
How large was the observed effect?: 16 of 23 multivariate studies.
What do the results mean in everyday life?: Weight loss in cancer needs attention.
What are the study's limitations?: Observational; Pfizer funding.
What does it say about Elawady's specific claim?: Supports the kernel only.
Do the results apply to Germany and Europe?: High.
What can explicitly not be concluded from this study?: That wasting rather than cancer kills.

Authors: Dunne RF et al.
Journal: J Cachexia Sarcopenia Muscle
Year: 2024
Identifier: PMID 39095951 DOI 10.1002/jcsm.13510
Verification: verified – PubMed efetch 2026-10-26 + Crossref
Retracted: no
Corrections: none
Extent checked: abstract only
Conflicts of interest and funding: Funded by Pfizer; several authors with industry honoraria (PubMed record)

Is cachexia or weight loss associated with survival in colorectal or pancreatic cancer?

Study design: Systematic review – Systematic literature review (PRISMA) of observational studies
Population: Adults with colorectal or pancreatic cancer (studies with >=100 patients)
Country: Mainly Europe and USA
Period: Publications 2016-2021
Sample size: 26 publications
Inclusion and exclusion criteria: Cachexia by consensus criteria or any weight loss; survival reported

Exposure / intervention: Cachexia / weight loss
Comparator: No cachexia / less weight loss
Endpoints: Survival
Statistical methods: Narrative synthesis of multivariate/univariate analyses

Results: Cachexia or weight loss was associated with significantly poorer survival in 16 of 23 studies using multivariate analysis and 1 of 3 using univariate analysis (nearly two-thirds overall).
Absolute risks: not reported
Authors' conclusion: Cachexia or weight loss is associated with poorer survival in nearly two-thirds of studies; routine weight assessment could inform prognosis.

Vote counting; no pooled effect.

Confirms the correct kernel that wasting is linked to death in cancer; it does not show that wasting is independent of the cancer.

Association could reflect more advanced or aggressive cancer.

High.

Supports 'wasting matters', not 'patients do not die of cancer'.

Multidimensional assessment
Multidimensional assessment
Authenticity of the source	verified
Methodological quality	moderate
Risk of bias	some concerns
Precision of results	not applicable
Directness	direct
Reproducibility	partly replicated
Consistency with the overall evidence	mixed
Regional transferability	high
Adequacy of the interpretation (by the archive)	not applicable